Top Qs
Timeline
Chat
Perspective
Elapegademase
Pharmaceutical compound From Wikipedia, the free encyclopedia
Remove ads
Elapegademase, sold under the brand name Revcovi, is a medication for the treatment of the rare disease adenosine deaminase deficiency-SCID in children and adults.[1]
It is a recombinant enzyme[2] that is administered weekly by intramuscular injection.[3]
Elapegademase may interact with PEGylated drugs.[3]
Elapegademase-lvlr was approved by the U.S. Food and Drug Administration (FDA) in 2018.[4][5][6] Leadiant Biosciences was awarded a priority review voucher for its development under the pediatric rare diseases program.[7]
Remove ads
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads